Effect of Incentive Spirometery on Asthmatic Pregnant Women
NCT ID: NCT05904002
Last Updated: 2023-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2020-09-20
2022-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Uterine Peristalsis in IVF
NCT06036459
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
NCT04548102
Effect of Kinesiotape on Emesis in Pregnant Women
NCT06625632
Endometrial Injury for Unexplained Infertility
NCT02863198
Covid 19 Vaccine Acceptance in Egyptian Pregnant Women
NCT05258760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pulmicort inhaler
Group (A) consists of 30 patients. They will receive their inhaled glucocorticoids (pulmicort inhaler) on needs.
pulmicort inhaler
Each woman in both groups (A\&B) will receive pulmicort inhaler on needs.
incentive spirometer
Group (B) consists of 30 patients. They will receive the same medical treatment and incentive spirometer program 3 days per week for six weeks.
pulmicort inhaler
Each woman in both groups (A\&B) will receive pulmicort inhaler on needs.
Incentive spirometer treatment
Each patient in group B will be instructed about the effects of incentive spirometer to gain their cooperation during the study course.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pulmicort inhaler
Each woman in both groups (A\&B) will receive pulmicort inhaler on needs.
Incentive spirometer treatment
Each patient in group B will be instructed about the effects of incentive spirometer to gain their cooperation during the study course.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Their age will range from 30 to40years old.
2. Body mass index (BMI) will range from 25-29.9 kg/m2.
3. All patients will be clinically and medically stable.
Exclusion Criteria
1. Diabetes mellitus.
2. Severe hypertension.
3. Neurological and neuromuscular disorders.
4. Blindness.
5. Developed moderate and severe degree of pleural effusion.
6. Cardiovascular instability.
7. Chronic chest disease.
30 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eman Amin Soliman
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Outpatient clinic faculty of physical therapy cairo university
Dokki, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Eman_Amin_2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.